Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 62

1.

Efficacy and safety of artemether-lumefantrine as treatment for Plasmodium falciparum uncomplicated malaria in adult patients on efavirenz-based antiretroviral therapy in Zambia: an open label non-randomized interventional trial.

Banda CG, Chaponda M, Mukaka M, Mulenga M, Hachizovu S, Kabuya JB, Mulenga J, Sikalima J, Kalilani-Phiri L, Terlouw DJ, Khoo SH, Lalloo DG, Mwapasa V.

Malar J. 2019 May 24;18(1):180. doi: 10.1186/s12936-019-2818-7.

2.

HIV testing and counselling couples together for affordable HIV prevention in Africa.

Wall KM, Inambao M, Kilembe W, Karita E, Vwalika B, Mulenga J, Parker R, Sharkey T, Sonti D, Tichacek A, Hunter E, Yohnka R, Abdallah JF, Thior I, Pulerwitz J, Allen S.

Int J Epidemiol. 2019 Feb 1;48(1):217-227. doi: 10.1093/ije/dyy203.

3.

Chronic hepatitis B virus monoinfection at a university hospital in Zambia.

Vinikoor MJ, Sinkala E, Kanunga A, Muchimba M, Nsokolo B, Chilengi R, Wandeler G, Mulenga J, Chisenga T, Bhattacharya D, Saag MS, Foster G, Fried MW, Kelly P.

World J Hepatol. 2018 Sep 27;10(9):622-628. doi: 10.4254/wjh.v10.i9.622.

4.

Difficult decisions: Evaluating individual and couple-level fertility intentions and HIV acquisition among HIV serodiscordant couples in Zambia.

Joseph Davey DL, Wall KM, Kilembe W, Khu NH, Brill I, Vwalika B, Chomba E, Mulenga J, Tichacek A, Gorbach PM, Allen S.

PLoS One. 2018 Jan 24;13(1):e0189869. doi: 10.1371/journal.pone.0189869. eCollection 2018.

5.

Factors associated with postnatal care for newborns in Zambia: analysis of the 2013-14 Zambia demographic and health survey.

Bwalya BB, Mulenga MC, Mulenga JN.

BMC Pregnancy Childbirth. 2017 Dec 13;17(1):418. doi: 10.1186/s12884-017-1612-1.

6.

Erratum to: Risky Sex and HIV Acquisition Among HIV Serodiscordant Couples in Zambia, 2002-2012: What Does Alcohol Have To Do With It?

Joseph Davey D, Kilembe W, Wall KM, Khu NH, Brill I, Vwalika B, Chomba E, Mulenga J, Tichacek A, Javanbakht M, Comulada WS, Allen S, Gorbach PM.

AIDS Behav. 2018 Jul;22(7):2386. doi: 10.1007/s10461-017-1908-1.

PMID:
28956345
7.

HIV Incidence and Predictors of HIV Acquisition From an Outside Partner in Serodiscordant Couples in Lusaka, Zambia.

Joseph Davey DL, Wall KM, Kilembe W, Naw HK, Brill I, Vwalika B, Chomba E, Mulenga J, Tichacek A, Javanbakt M, Gorbach PM, Allen SA.

J Acquir Immune Defic Syndr. 2017 Oct 1;76(2):123-131. doi: 10.1097/QAI.0000000000001494.

8.

Artemisinin-based combination therapy in pregnant women in Zambia: efficacy, safety and risk of recurrent malaria.

Nambozi M, Kabuya JB, Hachizovu S, Mwakazanga D, Mulenga J, Kasongo W, Buyze J, Mulenga M, Van Geertruyden JP, D'Alessandro U.

Malar J. 2017 May 16;16(1):199. doi: 10.1186/s12936-017-1851-7.

9.

Risk of heterosexual HIV transmission attributable to sexually transmitted infections and non-specific genital inflammation in Zambian discordant couples, 1994-2012.

Wall KM, Kilembe W, Vwalika B, Haddad LB, Hunter E, Lakhi S, Chavuma R, Htee Khu N, Brill I, Vwalika C, Mwananyanda L, Chomba E, Mulenga J, Tichacek A, Allen S.

Int J Epidemiol. 2017 Oct 1;46(5):1593-1606. doi: 10.1093/ije/dyx045.

10.

Risky Sex and HIV Acquisition Among HIV Serodiscordant Couples in Zambia, 2002-2012: What Does Alcohol Have To Do With It?

Joseph Davey D, Kilembe W, Wall KM, Khu NH, Brill I, Vwalika B, Chomba E, Mulenga J, Tichacek A, Javanbakht M, Comulada WS, Allen S, Gorbach PM.

AIDS Behav. 2017 Jul;21(7):1892-1903. doi: 10.1007/s10461-017-1733-6. Erratum in: AIDS Behav. 2017 Sep 27;:.

11.

Sustained effect of couples' HIV counselling and testing on risk reduction among Zambian HIV serodiscordant couples.

Wall KM, Kilembe W, Vwalika B, Haddad LB, Lakhi S, Onwubiko U, Htee Khu N, Brill I, Chavuma R, Vwalika C, Mwananyanda L, Chomba E, Mulenga J, Tichacek A, Allen S.

Sex Transm Infect. 2017 Jun;93(4):259-266. doi: 10.1136/sextrans-2016-052743. Epub 2017 Jan 12.

12.

Four artemisinin-based treatments in African pregnant women with malaria.

PREGACT Study Group, Pekyi D, Ampromfi AA, Tinto H, Traoré-Coulibaly M, Tahita MC, Valéa I, Mwapasa V, Kalilani-Phiri L, Kalanda G, Madanitsa M, Ravinetto R, Mutabingwa T, Gbekor P, Tagbor H, Antwi G, Menten J, De Crop M, Claeys Y, Schurmans C, Van Overmeir C, Thriemer K, Van Geertruyden JP, D'Alessandro U, Nambozi M, Mulenga M, Hachizovu S, Kabuya JB, Mulenga J.

Malawi Med J. 2016 Sep;28(3):139-149.

13.

Four Artemisinin-Based Treatments in African Pregnant Women with Malaria.

PREGACT Study Group, Pekyi D, Ampromfi AA, Tinto H, Traoré-Coulibaly M, Tahita MC, Valéa I, Mwapasa V, Kalilani-Phiri L, Kalanda G, Madanitsa M, Ravinetto R, Mutabingwa T, Gbekor P, Tagbor H, Antwi G, Menten J, De Crop M, Claeys Y, Schurmans C, Van Overmeir C, Thriemer K, Van Geertruyden JP, D'Alessandro U, Nambozi M, Mulenga M, Hachizovu S, Kabuya JB, Mulenga J.

N Engl J Med. 2016 Mar 10;374(10):913-27. doi: 10.1056/NEJMoa1508606.

14.

Hormonal Contraception, Pregnancy, Breastfeeding, and Risk of HIV Disease Progression Among Zambian Women.

Wall KM, Kilembe W, Haddad L, Vwalika B, Lakhi S, Khu NH, Brill I, Chomba E, Mulenga J, Tichacek A, Allen S.

J Acquir Immune Defic Syndr. 2016 Mar 1;71(3):345-52. doi: 10.1097/QAI.0000000000000848.

15.

Effect of seasonal variation on adult clinical laboratory parameters in Rwanda, Zambia, and Uganda: implications for HIV biomedical prevention trials.

Ruzagira E, Abaasa A, Karita E, Mulenga J, Kilembe W, Allen S, Bahemuka U, Bwanika AN, Levin J, Price MA, Kamali A.

PLoS One. 2014 Aug 13;9(8):e105089. doi: 10.1371/journal.pone.0105089. eCollection 2014.

16.

Low antibody-dependent cellular cytotoxicity responses in Zambians prior to HIV-1 intrasubtype C superinfection.

Basu D, Xiao P, Ende Z, Bere A, Britt WJ, Mulenga J, Kilembe W, Allen SA, Derdeyn CA, Hunter E.

Virology. 2014 Aug;462-463:295-8. doi: 10.1016/j.virol.2014.06.016. Epub 2014 Jul 5.

17.

Reply to Yang et al.

Dionne-Odom J, Karita E, Kilembe W, Henderson F, Vwalika B, Bayingana R, Li Z, Mulenga J, Chomba E, del Rio C, Khu NH, Tichacek A, Allen S.

Clin Infect Dis. 2013 Oct;57(8):1212-3. doi: 10.1093/cid/cit353. Epub 2013 May 24. No abstract available.

18.

HLA-A*68:02-restricted Gag-specific cytotoxic T lymphocyte responses can drive selection pressure on HIV but are subdominant and ineffective.

Kløverpris HN, Stryhn A, Harndahl M, Carlson JM, Leslie AJ, Chen F, Riddell L, Mulenga J, Walker BD, Ndung'u T, Buus S, Goulder P.

AIDS. 2013 Jul 17;27(11):1717-23. doi: 10.1097/QAD.0b013e32836146cd.

19.

Syphilis treatment response among HIV-discordant couples in Zambia and Rwanda.

Dionne-Odom J, Karita E, Kilembe W, Henderson F, Vwalika B, Bayingana R, Li Z, Mulenga J, Chomba E, Del Rio C, Khu NH, Tichacek A, Allen S.

Clin Infect Dis. 2013 Jun;56(12):1829-37. doi: 10.1093/cid/cit146. Epub 2013 Mar 13.

20.

Peer support groups as an intervention to decrease epilepsy-associated stigma.

Elafros MA, Mulenga J, Mbewe E, Haworth A, Chomba E, Atadzhanov M, Birbeck GL.

Epilepsy Behav. 2013 Apr;27(1):188-92. doi: 10.1016/j.yebeh.2013.01.005. Epub 2013 Mar 1.

21.

Role of transmitted Gag CTL polymorphisms in defining replicative capacity and early HIV-1 pathogenesis.

Prince JL, Claiborne DT, Carlson JM, Schaefer M, Yu T, Lahki S, Prentice HA, Yue L, Vishwanathan SA, Kilembe W, Goepfert P, Price MA, Gilmour J, Mulenga J, Farmer P, Derdeyn CA, Tang J, Heckerman D, Kaslow RA, Allen SA, Hunter E.

PLoS Pathog. 2012;8(11):e1003041. doi: 10.1371/journal.ppat.1003041. Epub 2012 Nov 29.

22.

HIV-1 subtype C superinfected individuals mount low autologous neutralizing antibody responses prior to intrasubtype superinfection.

Basu D, Kraft CS, Murphy MK, Campbell PJ, Yu T, Hraber PT, Irene C, Pinter A, Chomba E, Mulenga J, Kilembe W, Allen SA, Derdeyn CA, Hunter E.

Retrovirology. 2012 Sep 20;9:76. doi: 10.1186/1742-4690-9-76.

23.

Promotion of couples' voluntary HIV counselling and testing in Lusaka, Zambia by influence network leaders and agents.

Wall KM, Kilembe W, Nizam A, Vwalika C, Kautzman M, Chomba E, Tichacek A, Sardar G, Casanova D, Henderson F, Mulenga J, Kleinbaum D, Allen S.

BMJ Open. 2012 Sep 6;2(5). pii: e001171. doi: 10.1136/bmjopen-2012-001171. Print 2012.

24.

A gp41-based heteroduplex mobility assay provides rapid and accurate assessment of intrasubtype epidemiological linkage in HIV type 1 heterosexual transmission Pairs.

Manigart O, Boeras DI, Karita E, Hawkins PA, Vwalika C, Makombe N, Mulenga J, Derdeyn CA, Allen S, Hunter E.

AIDS Res Hum Retroviruses. 2012 Dec;28(12):1745-55. doi: 10.1089/AID.2012.0023. Epub 2012 Jul 3.

25.

HLA-B signal peptide polymorphism influences the rate of HIV-1 acquisition but not viral load.

Merino AM, Song W, He D, Mulenga J, Allen S, Hunter E, Tang J, Kaslow RA.

J Infect Dis. 2012 Jun 15;205(12):1797-805. doi: 10.1093/infdis/jis275. Epub 2012 Apr 5.

26.

Timing and source of subtype-C HIV-1 superinfection in the newly infected partner of Zambian couples with disparate viruses.

Kraft CS, Basu D, Hawkins PA, Hraber PT, Chomba E, Mulenga J, Kilembe W, Khu NH, Derdeyn CA, Allen SA, Manigart O, Hunter E.

Retrovirology. 2012 Mar 20;9:22. doi: 10.1186/1742-4690-9-22.

27.

Prevalence of seroconversion symptoms and relationship to set-point viral load: findings from a subtype C epidemic, 1995-2009.

Sullivan PS, Fideli U, Wall KM, Chomba E, Vwalika C, Kilembe W, Tichacek A, Luisi N, Mulenga J, Hunter E, Boeras D, Allen S.

AIDS. 2012 Jan 14;26(2):175-84. doi: 10.1097/QAD.0b013e32834ed8c8.

28.

Role of donor genital tract HIV-1 diversity in the transmission bottleneck.

Boeras DI, Hraber PT, Hurlston M, Evans-Strickfaden T, Bhattacharya T, Giorgi EE, Mulenga J, Karita E, Korber BT, Allen S, Hart CE, Derdeyn CA, Hunter E.

Proc Natl Acad Sci U S A. 2011 Nov 15;108(46):E1156-63. doi: 10.1073/pnas.1103764108. Epub 2011 Nov 7.

29.

Genetic variations and heterosexual HIV-1 infection: analysis of clustered genes encoding CC-motif chemokine ligands.

Hu L, Song W, Brill I, Mulenga J, Allen S, Hunter E, Shrestha S, Tang J, Kaslow RA.

Genes Immun. 2012 Feb;13(2):202-5. doi: 10.1038/gene.2011.70. Epub 2011 Oct 6. Erratum in: Genes Immun. 2012 Jul;13(5):444.

30.

HIV, Hepatitis B, and Hepatitis C in Zambia.

Kapembwa KC, Goldman JD, Lakhi S, Banda Y, Bowa K, Vermund SH, Mulenga J, Chama D, Chi BH.

J Glob Infect Dis. 2011 Jul;3(3):269-74. doi: 10.4103/0974-777X.83534.

31.

Disparate associations of HLA class I markers with HIV-1 acquisition and control of viremia in an African population.

Song W, He D, Brill I, Malhotra R, Mulenga J, Allen S, Hunter E, Tang J, Kaslow RA.

PLoS One. 2011;6(8):e23469. doi: 10.1371/journal.pone.0023469. Epub 2011 Aug 17.

32.

Association of chemokine receptor gene (CCR2-CCR5) haplotypes with acquisition and control of HIV-1 infection in Zambians.

Malhotra R, Hu L, Song W, Brill I, Mulenga J, Allen S, Hunter E, Shrestha S, Tang J, Kaslow RA.

Retrovirology. 2011 Mar 23;8:22. doi: 10.1186/1742-4690-8-22.

33.

Lack of detectable HIV-1-specific CD8(+) T cell responses in Zambian HIV-1-exposed seronegative partners of HIV-1-positive individuals.

Addo MM, Altfeld M, Brainard DM, Rathod A, Piechocka-Trocha A, Fideli U, Mulenga J, Shutes E, Alvino DM, Hunter E, Allen SA, Walker BD.

J Infect Dis. 2011 Jan 15;203(2):258-62. doi: 10.1093/infdis/jiq028. Epub 2010 Dec 9.

34.

Impact of a functional KIR2DS4 allele on heterosexual HIV-1 transmission among discordant Zambian couples.

Merino A, Malhotra R, Morton M, Mulenga J, Allen S, Hunter E, Tang J, Kaslow RA.

J Infect Dis. 2011 Feb 15;203(4):487-95. doi: 10.1093/infdis/jiq075. Epub 2011 Jan 7.

35.

The B cell response is redundant and highly focused on V1V2 during early subtype C infection in a Zambian seroconverter.

Lynch RM, Rong R, Boliar S, Sethi A, Li B, Mulenga J, Allen S, Robinson JE, Gnanakaran S, Derdeyn CA.

J Virol. 2011 Jan;85(2):905-15. doi: 10.1128/JVI.02006-10. Epub 2010 Oct 27.

36.

Subtype-specific conservation of isoleucine 309 in the envelope V3 domain is linked to immune evasion in subtype C HIV-1 infection.

Lynch RM, Rong R, Li B, Shen T, Honnen W, Mulenga J, Allen S, Pinter A, Gnanakaran S, Derdeyn CA.

Virology. 2010 Aug 15;404(1):59-70. doi: 10.1016/j.virol.2010.04.010. Epub 2010 May 21.

37.

Nonpathogenic simian immunodeficiency virus infection of sooty mangabeys is not associated with high levels of autologous neutralizing antibodies.

Li B, Stefano-Cole K, Kuhrt DM, Gordon SN, Else JG, Mulenga J, Allen S, Sodora DL, Silvestri G, Derdeyn CA.

J Virol. 2010 Jun;84(12):6248-53. doi: 10.1128/JVI.00295-10. Epub 2010 Apr 7.

38.

Human leukocyte antigens and HIV type 1 viral load in early and chronic infection: predominance of evolving relationships.

Tang J, Malhotra R, Song W, Brill I, Hu L, Farmer PK, Mulenga J, Allen S, Hunter E, Kaslow RA.

PLoS One. 2010 Mar 10;5(3):e9629. doi: 10.1371/journal.pone.0009629.

39.

Donor and recipient envs from heterosexual human immunodeficiency virus subtype C transmission pairs require high receptor levels for entry.

Alexander M, Lynch R, Mulenga J, Allen S, Derdeyn CA, Hunter E.

J Virol. 2010 Apr;84(8):4100-4. doi: 10.1128/JVI.02068-09. Epub 2010 Feb 10.

40.

HIV-Selectest enzyme immunoassay and rapid test: ability to detect seroconversion following HIV-1 infection.

Khurana S, Norris PJ, Busch MP, Haynes BF, Park S, Sasono P, Mlisana K, Salim AK, Hecht FM, Mulenga J, Chomba E, Hunter E, Allen S, Nemo G, Rodriguez-Chavez IR; Women's Interagency HIV Study Collaborative Study Group, Margolick JB; Multicenter AIDS Cohort Study (MACS), Golding H.

J Clin Microbiol. 2010 Jan;48(1):281-5. doi: 10.1128/JCM.01573-09. Epub 2009 Nov 11.

41.

Escape from autologous neutralizing antibodies in acute/early subtype C HIV-1 infection requires multiple pathways.

Rong R, Li B, Lynch RM, Haaland RE, Murphy MK, Mulenga J, Allen SA, Pinter A, Shaw GM, Hunter E, Robinson JE, Gnanakaran S, Derdeyn CA.

PLoS Pathog. 2009 Sep;5(9):e1000594. doi: 10.1371/journal.ppat.1000594. Epub 2009 Sep 18.

42.

Heterosexual transmission of human immunodeficiency virus type 1 subtype C: Macrophage tropism, alternative coreceptor use, and the molecular anatomy of CCR5 utilization.

Isaacman-Beck J, Hermann EA, Yi Y, Ratcliffe SJ, Mulenga J, Allen S, Hunter E, Derdeyn CA, Collman RG.

J Virol. 2009 Aug;83(16):8208-20. doi: 10.1128/JVI.00296-09. Epub 2009 Jun 10.

43.

Genetic identity, biological phenotype, and evolutionary pathways of transmitted/founder viruses in acute and early HIV-1 infection.

Salazar-Gonzalez JF, Salazar MG, Keele BF, Learn GH, Giorgi EE, Li H, Decker JM, Wang S, Baalwa J, Kraus MH, Parrish NF, Shaw KS, Guffey MB, Bar KJ, Davis KL, Ochsenbauer-Jambor C, Kappes JC, Saag MS, Cohen MS, Mulenga J, Derdeyn CA, Allen S, Hunter E, Markowitz M, Hraber P, Perelson AS, Bhattacharya T, Haynes BF, Korber BT, Hahn BH, Shaw GM.

J Exp Med. 2009 Jun 8;206(6):1273-89. doi: 10.1084/jem.20090378. Epub 2009 Jun 1.

44.

Evolution of HLA-B*5703 HIV-1 escape mutations in HLA-B*5703-positive individuals and their transmission recipients.

Crawford H, Lumm W, Leslie A, Schaefer M, Boeras D, Prado JG, Tang J, Farmer P, Ndung'u T, Lakhi S, Gilmour J, Goepfert P, Walker BD, Kaslow R, Mulenga J, Allen S, Goulder PJ, Hunter E.

J Exp Med. 2009 Apr 13;206(4):909-21. doi: 10.1084/jem.20081984. Epub 2009 Mar 23.

45.

Adaptation of HIV-1 to human leukocyte antigen class I.

Kawashima Y, Pfafferott K, Frater J, Matthews P, Payne R, Addo M, Gatanaga H, Fujiwara M, Hachiya A, Koizumi H, Kuse N, Oka S, Duda A, Prendergast A, Crawford H, Leslie A, Brumme Z, Brumme C, Allen T, Brander C, Kaslow R, Tang J, Hunter E, Allen S, Mulenga J, Branch S, Roach T, John M, Mallal S, Ogwu A, Shapiro R, Prado JG, Fidler S, Weber J, Pybus OG, Klenerman P, Ndung'u T, Phillips R, Heckerman D, Harrigan PR, Walker BD, Takiguchi M, Goulder P.

Nature. 2009 Apr 2;458(7238):641-5. doi: 10.1038/nature07746. Epub 2009 Feb 25.

46.

CLSI-derived hematology and biochemistry reference intervals for healthy adults in eastern and southern Africa.

Karita E, Ketter N, Price MA, Kayitenkore K, Kaleebu P, Nanvubya A, Anzala O, Jaoko W, Mutua G, Ruzagira E, Mulenga J, Sanders EJ, Mwangome M, Allen S, Bwanika A, Bahemuka U, Awuondo K, Omosa G, Farah B, Amornkul P, Birungi J, Yates S, Stoll-Johnson L, Gilmour J, Stevens G, Shutes E, Manigart O, Hughes P, Dally L, Scott J, Stevens W, Fast P, Kamali A.

PLoS One. 2009;4(2):e4401. doi: 10.1371/journal.pone.0004401. Epub 2009 Feb 6.

47.

Inflammatory genital infections mitigate a severe genetic bottleneck in heterosexual transmission of subtype A and C HIV-1.

Haaland RE, Hawkins PA, Salazar-Gonzalez J, Johnson A, Tichacek A, Karita E, Manigart O, Mulenga J, Keele BF, Shaw GM, Hahn BH, Allen SA, Derdeyn CA, Hunter E.

PLoS Pathog. 2009 Jan;5(1):e1000274. doi: 10.1371/journal.ppat.1000274. Epub 2009 Jan 23.

48.

Human leukocyte antigen class I genotypes in relation to heterosexual HIV type 1 transmission within discordant couples.

Tang J, Shao W, Yoo YJ, Brill I, Mulenga J, Allen S, Hunter E, Kaslow RA.

J Immunol. 2008 Aug 15;181(4):2626-35.

49.

Baseline morbidity in 2,990 adult African volunteers recruited to characterize laboratory reference intervals for future HIV vaccine clinical trials.

Stevens W, Kamali A, Karita E, Anzala O, Sanders EJ, Jaoko W, Kaleebu P, Mulenga J, Dally L, Fast P, Gilmour J, Farah B, Birungi J, Hughes P, Manigart O, Stevens G, Yates S, Thomson H, von Lieven A, Krebs M, Price MA, Stoll-Johnson L, Ketter N.

PLoS One. 2008 Apr 30;3(4):e2043. doi: 10.1371/journal.pone.0002043.

50.

Transmission of HIV-1 Gag immune escape mutations is associated with reduced viral load in linked recipients.

Goepfert PA, Lumm W, Farmer P, Matthews P, Prendergast A, Carlson JM, Derdeyn CA, Tang J, Kaslow RA, Bansal A, Yusim K, Heckerman D, Mulenga J, Allen S, Goulder PJ, Hunter E.

J Exp Med. 2008 May 12;205(5):1009-17. doi: 10.1084/jem.20072457. Epub 2008 Apr 21.

Supplemental Content

Loading ...
Support Center